详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Jiang, Qian[1] ; Li, Zongru[1] ; Qin, Yazhen[1] ; Li, Weiming[2] ; Xu, Na[3] ; Liu, Bingcheng[4] ; Zhang, Yanli[5,6] ; Meng, Li[7] ; Zhu, Huanling[8] ; Du, Xin[9] ; Chen, Suning[10] ; Liang, Yang[11] ; Hu, Yu[2] ; Liu, Xiaoli[3] ; Song, Yongping[5,6] ; Men, Lichuang[12] ; Chen, Zi[12] ; Niu, Qian[12] ; Wang, Hengbang[12] ; Lu, Ming[13] ; Yang, Dajun[14,15] ; Zhai, Yifan[12,13] ; Huang, Xiaojun[1,16,17,18] ;

机构： [1]Peking Univ, Peking Univ Peoples Hosp, Natl Clin Res Ctr Hematol Dis, Inst Hematol, 11 South St Xizhimen, Beijing 100044, Peoples R China [2]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China [3]Southern Med Univ, Nanfang Hosp, Dept Hematol, 1838 Guangzhou N Ave, Guangzhou 510515, Guangdong, Peoples R China [4]Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin 300020, Peoples R China [5]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China [6]Henan Canc Hosp, Zhengzhou 450008, Henan, Peoples R China [7]Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan 430022, Hubei, Peoples R China [8]Sichuan Univ, Dept Hematol, West China Hosp, 37 Guoxue Alley, Chengdu 610000, Sichuan, Peoples R China [9]Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Div Hematol, 3002 Sungang W Rd, Shenzhen 518000, Guangdong, Peoples R China [10]Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol,Inst Blood & Marrow Transpla, Suzhou, Peoples R China [11]Sun Yat Sen Univ, Dept Hematol Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China [12]Guangzhou Healthquest Pharma Co Ltd, Room F314,GIBI,3 Lanyue Rd, Guangzhou 510663, Peoples R China [13]Ascentage Pharma Grp Inc, 800 King Farm Blvd Suite 300, Rockville, MD 20850 USA [14]Ascentage Pharma Suzhou Co Ltd, 218 Xinghu St,Bldg B7,7Th Floor,Suzhou Ind Pk, Suzhou 215000, Jiangsu, Peoples R China [15]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China [16]Beijing Key Lab Hematopoiet Stem Cell Transplanta, 11 South St Xizhimen, Beijing 100044, Peoples R China [17]Peking Tsinghua Ctr Life Sci, 11 South St Xizhimen, Beijing 100044, Peoples R China [18]Peking Univ, Acad Adv Interdisciplinary Studies, 11 South St Xizhimen, Beijing 100044, Peoples R China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区血液学 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学 1 区肿瘤学

JCR分区：

出版当年[2022]版：

Q1 HEMATOLOGY Q1 ONCOLOGY

最新[2023]版：

Q1 HEMATOLOGY Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Peking Univ, Peking Univ Peoples Hosp, Natl Clin Res Ctr Hematol Dis, Inst Hematol, 11 South St Xizhimen, Beijing 100044, Peoples R China

通讯作者：

通讯机构： [1]Peking Univ, Peking Univ Peoples Hosp, Natl Clin Res Ctr Hematol Dis, Inst Hematol, 11 South St Xizhimen, Beijing 100044, Peoples R China [16]Beijing Key Lab Hematopoiet Stem Cell Transplanta, 11 South St Xizhimen, Beijing 100044, Peoples R China [17]Peking Tsinghua Ctr Life Sci, 11 South St Xizhimen, Beijing 100044, Peoples R China [18]Peking Univ, Acad Adv Interdisciplinary Studies, 11 South St Xizhimen, Beijing 100044, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial (vol 15, 113, 2022)

文献详情